Personal view: current role of artificial liver support devices

@article{Ogrady2006PersonalVC,
  title={Personal view: current role of artificial liver support devices},
  author={John G O'grady},
  journal={Alimentary Pharmacology \& Therapeutics},
  year={2006},
  volume={23}
}
  • J. O'grady
  • Published 1 June 2006
  • Medicine
  • Alimentary Pharmacology & Therapeutics
Enthusiasm for liver support devices, particularly cell‐based biological systems and albumin dialysis, increased over the last decade and there has been considerable clinical activity both within and without the construct of clinical trials. Most data have been generated on patients with acute liver failure or in patients with decompensation of chronic liver disease, often referred to as acute‐on‐chronic liver failure. 
Future of bioartificial liver support.
  • R. Chamuleau
  • Medicine
    World journal of gastrointestinal surgery
  • 2009
TLDR
Which hurdles have to be taken before the BAL will become standard equipment in the intensive care unit for patients with acute liver failure or acute deterioration of chronic liver disease are analyzed.
Liver support devices
The liver performs a myriad of functions including immune, metabolic, synthetic and excretory functions, which play a crucial role in maintaining function of other organs and body homeostasis.1
Extracorporeal Non cellular Liver Assisted Devices
TLDR
This chapter elaborates the currently available extracorporeal non cellular liver assist devices that includes Molecular adsorbent recirculating system (MARS), Prometheus—Fractionated plasma separation and adsorption system (FSPA), Single pass albumin dialysis (SPAD), and Selective plasma filtration therapy (SEPET) in an effort to support patients with end stages liver failure until a graft will become available or facilitate regeneration.
Albumin dialysis: an update
  • S. Mitzner
  • Medicine
    Current opinion in nephrology and hypertension
  • 2007
TLDR
Albumin regeneration has developed into a central component of modern liver support technologies and is the most frequently used and best studied liver support technique at present time.
MARS®: a futile tool in centres without active liver transplant support
  • C. Wai, Seng-Gee Lim, +9 authors Kan-Hoe Lee
  • Medicine
    Liver international : official journal of the International Association for the Study of the Liver
  • 2007
TLDR
Research showed inconclusive survival benefits in studies on Molecular Adsorbent Recycling Systems (MARS®), so further studies are needed to establish a cause-and-effect relationship.
Albumin in Artificial Liver Support Systems
While liver transplantation is the only accepted therapy for liver failure, bound solute dialysis (BSD) may provide an alternative. Current BSD methods, MARS and SPAD, are unfortunately poorly
Partial portal vein arterialization in acute liver failure
TLDR
Positive experience is reported in the realization and clinical application of an extracorporeal device able to increase the oxygenated blood delivered to the liver through the umbilical vein and to support liver function in a man subjected to an extended liver resection.
Current status of auxiliary partial orthotopic liver transplantation for acute liver failure
  • M. Rela, I. Kaliamoorthy, M. Reddy
  • Medicine
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2016
TLDR
Results of this procedure have continued to improve with improving surgical techniques and a better understanding of the natural history of acute liver failure (ALF) and liver regeneration.
Portal vein arterialization in hepatobiliary surgery and liver transplantation.
TLDR
The PPVA procedure has shown itself to be safe and simple as well as to offer a promising approach to the failing liver to prevent and treat acute liver failure.
Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy.
TLDR
MARS was safe and well tolerated, improving biochemical parameters, neurological function, and pruritus, and the association of MARS with a transplant/retransplantation procedure was highly effective.
...
1
2
3
...

References

SHOWING 1-10 OF 59 REFERENCES
Liver Assist Systems: State of the Art
TLDR
The authors review the current status of liver assist systems and summarize their clinical experience with a xenogeneic cell based-bioartificial liver.
Liver support by extracorporeal blood purification: A clinical observation
  • J. Stange, S. Mitzner, +12 authors U. Hopt
  • Medicine
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2000
TLDR
It is concluded that in acute excretory failure caused by a chronic liver disease, this treatment provides a therapy option to remove toxins involved in multiorgan dysfunction secondary to liver failure.
Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: system modifications and clinical impact
TLDR
The patients tolerated treatment with the ELAD well, and the results from this single-institution experience indicates that larger randomized multicenter trials should proceed.
Results of a phase I trial evaluating a liver support device utilizing albumin dialysis.
TLDR
This phase I study suggests that albumin dialysis as a liver support device is safe and effective in clearing hepatic toxins, with an associated decrease in the HES and ICP.
Pilot‐controlled trial of the extracorporeal liver assist device in acute liver failure
TLDR
Assessment of additive function for the device revealed an improvement in galactose elimination capacity after 6 hours of haemoperfusion, and better indices of prognosis will be required, in addition to those used to select for transplantation, if patients at an earlier stage of clinical deterioration are to be included in future studies.
Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial
  • S. Mitzner, J. Stange, +14 authors R. Schmidt
  • Medicine
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2000
TLDR
It is concluded that the removal of albumin‐bound substances with the MARS method can contribute to the treatment of type I HRS.
Prometheus--a new extracorporeal system for the treatment of liver failure.
TLDR
Prometheus is a safe supportive therapy for patients with liver failure and a significant improvement of the biochemical milieu was observed already after two treatments, and Prospective controlled studies are necessary to evaluate hard clinical end-points.
Clinical Application of Bioartificial Liver Support Systems
TLDR
Bioartificial liver therapy for bridging patients with ALF to liver transplantation or liver regeneration is promising, and its clinical value awaits further improvement of BAL devices, replacement of hepatocytes of animal origin by human hepatocytes, and assessment in controlled clinical trials.
Emerging Indications for Albumin Dialysis
TLDR
Clinical studies in the last decade have demonstrated proven reduction in hyperbilirubinemia, along with an improvement in encephalopathy in liver failure patients, as well as apparent improvement in survival.
Experiences with MARS liver support therapy in liver failure: analysis of 176 patients of the International MARS Registry.
TLDR
The data suggest an improved survival accompanied by significant improvements of hepatic encephalopathy, mean arterial pressure, serum bilirubin level, creatinine, urea, albumin, INR, ammonia and MELD score.
...
1
2
3
4
5
...